Skip to Content

Review: Nearly One in Five With SARS-CoV-2 Has GI Manifestations

FRIDAY, Nov. 6, 2020 -- Gastrointestinal manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection occur in about 18 percent of patients and can include loss of appetite, nausea, vomiting, and diarrhea, according to a review recently published in Abdominal Radiology.

Kevin Lui, from the University of Alberta in Edmonton, Canada, and colleagues conducted a systematic review that included case reports and series discussing radiologic manifestations of SARS-CoV-2 infection in abdominal imaging studies. Data from 36 studies were included in a qualitative synthesis.

The researchers found that the prevalence of gastrointestinal symptoms was about 18 percent; symptoms included loss of appetite, nausea, vomiting, diarrhea, and abdominal pain. Of COVID-19 cases, 16 percent may only present with gastrointestinal symptoms. Many patients who only present with gastrointestinal symptoms show incidental evidence of COVID-19 through abdominal computed tomography imaging at the lung bases. Abdominal imaging findings reported to date include small and large bowel wall thickening, fluid-filled colon, pneumatosis intestinalis, pneumoperitoneum, intussusception, and ascites.

"Gastrointestinal manifestations of COVID-19 have been increasingly recognized," the authors write. "Identifying these features on abdominal imaging highlight the need to consider and evaluate for other manifestations of COVID-19 such as lung parenchymal findings."

Abstract/Full Text

© 2021 HealthDay. All rights reserved.

Posted: November 2020

Read this next

Physician's Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 19 to 22, 2021. This roundup...

Adults Delaying Even Emergency Care During COVID-19

FRIDAY, Jan. 22, 2021 -- Two-thirds of Americans are concerned about going to medical appointments even for an emergency when COVID-19 rates are high in their area, according to...

Antibody Drug May Protect Nursing Home Residents, Staff From COVID-19

FRIDAY, Jan. 22, 2021 -- An antibody drug that has emergency use authorization from the U.S. Food and Drug Administration for use in early-stage COVID-19 patients with symptoms...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.